We investigated the basic thermoluminescence (TL) characteristics of Cr-doped low-meltingpoint Al 2 O 3 . The concentration of Cr 2 O 3 in this study ranged from 0.01 to 1.0 wt%. Owing to the stabilization of the trapped state caused by Cr doping, we successfully improved the lowmelting-point Al 2 O 3 fading property dramatically. Then, the sensitivity of 0.05 wt% Cr-doped Al 2 O 3 to X-rays was about 4.8 times higher than that of the nondoped Al 2 O 3 , allowing the Al 2 O 3 to maintain its attractive properties to X-rays. Furthermore, the 0.05 wt% Cr-doped Al 2 O 3 had good properties for dosimetry owing to its high TL sensitivity, high reproducibility, high radiation resistivity, and high thermal stability in two dimensions. Finally, we demonstrated two-dimensional (2D) verifications of radiotherapy (RT) plans using Cr-doped Al 2 O 3 ceramic plates. The results had good agreement with RT plans.
A thermoluminescent (TL) phosphor Li3B7O12:Cu was irradiated by a proton beam at NIRS-HIMAC in Japan. Irradiation was performed at different water-equivalent depths using range shifters made of polymethyl methacrylate. The thermoluminescent responses of Li3B7O12:Cu were analysed, focusing on the TL efficiency and glow curve. The irradiated samples were heated from room temperature to 200°C at 0.16°C s(-1). The high-temperature area of the glow curve under proton irradiation changed in comparison with that under (60)Co gamma-ray irradiation. The relative TL efficiency of the main peak slightly varied between 0.8 and 1.1. The relationship between the relative TL efficiency of the main peak and the high-temperature area ratio (HTR) value, the relative TL ratio of the main peak to the high-temperature area, showed approximate linearity for proton dosimetry. Using correction based on the HTR method, the TL phosphor Li3B7O12:Cu can become a useful dosimetric tool for therapeutic proton beams.
In this study, the feasibility of using a thermoluminescent slab dosimeter (TLSD) in postal dosimetry audit for radiotherapy systems is examined. First, changes in material structure are evaluated by measuring changes in TLSD weight and temperature after heating and cooling. Then, a fading correction factor is derived by measuring the relationship between the elapsed time after irradiation and thermoluminescence (TL) intensity. Finally, the uncertainty in the absorbed dosimetry using the TLSD with the TL absorbed dose correction factor is evaluated. It is shown that the TLSD weight and heat flow change after heating. These changes are reversible upon cooling. Therefore, the material structure of the TLSD does not change after heating. The fading effect for the TLSD can be minimized by setting the elapsed time to more than 100 h. Furthermore, measurement accuracy can be improved by correcting the fading. The overall measurement uncertainty or expanded relative standard uncertainty for this measurement method is 1.80%. The TLSD has high material stability and measurement accuracy under a certain condition equivalent to that of conventional postal dosimetry audit conducted using a glass dosimeter. The TLSD can be used as a 2D measurement device for postal dosimetry audit.
Despite their advantages, two-dimensional (2D) thermoluminescence dosimeters (TLDs) have not yet replaced film dosimeters owing to their nonuniformity and low repeatability. A 2D TLD based on Al 2 O 3 :Cr ceramics is a promising new reusable passive dosimeter. 2D Al 2 O 3 :Cr TLDs can be used for geometry check tests and dose distribution verification in robotic radiosurgery using monoenergetic X-ray beams. In this work, the dependence of energy on the field size and water depth of 2D Al 2 O 3 :Cr TLDs for 4, 6, and 10 MV X-ray beams was investigated, because multienergy X-ray beams are used in radiotherapy. Intensity-modulated radiotherapy plan verifications were performed using the TLDs. The TLDs were found to have a large field size dependence for each energy, but their water depth dependence was small at a water depth above 4 cm for each energy. The relative dose distributions were verified with high accuracy using the TLDs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.